Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
Clinical trial NCT05850494 · COMPLETED
Trial details
- NCT number
- NCT05850494
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-02
- Primary completion
- 2023-08-21
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.